Fasting blood glucose at admission as a predictor for mortality in patients with COVID-19 without previous diagnosis of diabetes

Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study – Diabetologia

Commentaries: Study links abnormally high blood sugar with higher risk of death in COVID-19 patients not previously diagnosed with diabetes – Diabetologia AND Expert reaction to study looking at blood sugar level and death in hospitalised COVID-19 patients in Wuhan – Science Media Centre